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Abstract
Background: In Switzerland, skin cancer is one of the most common neoplasms. Melanoma is the most aggressive
one and can be lethal if not detected and removed on time. Nonmelanoma skin cancer is more frequent as
melanoma; it is seldom lethal but can disfigure patients in advanced stages. General practitioners (GPs) are often
faced with suspicious skin lesions of their patients.
Methods/Design: Design: Randomised controlled trial (RCT).
Population: 60 GPs, randomised into intervention group and control group.
Intervention: GPs get a Lumio loupe, a digital camera and continuous feedback based on pictures of skin lesions
they send to the Dermatologist.
Primary outcome: Competence in the diagnosis of skin cancer by GPs, measured as the percentage of correctly
classified pictures of skin lesions.
Measurements: At baseline, and prior to any intervention (T0), GPs will be asked to rate 36 pictures of skin lesions
according to their likelihood of malignancy on a visual analogue scale (VAS). After a full day training course with
both groups (T1) and after one year of continuous feedback (T2) with the intervention group, we will repeat the
picture scoring session with both groups, using new pictures.
Discussion: We want to determine whether a multifaceted intervention (including technical equipment and a
continuous feedback on skin lesions) leads to an improved competence in the diagnosis of skin cancer by GPs.
This study addresses the hypothesis that an additional feedback loop, based on pictures performed in daily
practice by GPs is superior to a simple educational intervention regarding diagnostic competence. We expect an
improvement of the competence in skin cancer diagnosis by GPs in both groups after the full day training course.
Beside this immediate effect, we also expect a long term effect in the intervention group because of the
continuous problem based feedback.
Trial registration: ISRCTN: ISRCTN29854485
Background
Skin cancer is one of the most common neoplasms in
Switzerland [1] and in Central Europe Switzerland is
one of the countries with the highest prevalence of
melanoma [2].
There are three main types of skin cancer: basal cell
carcinoma (BCC), squamous cell carcinoma (SCC) and
melanoma. Within skin cancers, melanoma is the most
aggressive one and can be lethal if not detected and
removed on time. It is responsible for more than 90% of
all skin cancer related deaths. The lifetime risk for mela-
nomas in Switzerland for newborns of the year 2000 is
estimated to be 1:80 [3], there are currently approxi-
mately 1900 new cases of melanoma per year in
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Switzerland [1] and the rate of incidence continuously
increases. Due to a lack of adequate therapies for meta-
static melanoma, the best management option currently
remains early diagnosis and prompt surgical excision of
the primary cancer. If diagnosed and treated at early
stages most melanoma can be cured.
BCC and SCC (summarized as nonmelanoma skin
cancer, NMSC) are more frequent than melanoma; they
are less dangerous because they rarely spread in the
body. Due to their high incidence, their aggressive,
destructive growth pattern and their tendency to recur
after treatment, the morbidity and costs related to these
cancers are very high [4].
Due to the rapidly rising incidence of skin cancer, GPs
are more and more faced with suspicious skin lesions in
their patients. Appropriate knowledge and continuous
training about suspicious skin lesions are crucial to handle
these lesions correctly. An important condition for an
optimal patient care is the collaboration of GPs with
Dermatologists in a multidisciplinary treatment team [5].
Methods/Design
Hypothesis
A multifaceted intervention including technical equipment
and a continuous feedback (provided by a Dermatologist)
leads to an improved competence in the diagnosis of skin
cancer by GPs.
Study design
This study is a (prospective) randomised, two-armed
study; randomised and controlled at the GP level. The
intervention includes a Lumio loupe (magnifying glass
with integrated polarized light source allowing subsurface
examination), a digital camera and continuous feedback
on all pictures of skin lesions the GP sends to the
Dermatologist.
Primary outcome
Competence in the diagnosis of skin cancer by GPs,
measured as the percentage of correctly classified pic-
tures of skin lesions.
Inclusion criteria for general practitioners
All GPs in the Canton of Zurich will be invited to join the
study by postal letters and information sessions provided
by members of the study centre. 60 GPs are projected to
be part of the study. Any general practitioner who pro-
vides basic medical care with a workload of at least 20
hours per week, who does not plan to retire or to move
away during the study period is entitled to participate in
the study.
Procedure of the study
The procedure of the study is summarised in Figure 1.
Both groups
At baseline, and prior to any intervention (T0), the GPs
will be asked to rate 36 pictures of skin lesions accord-
ing to their likelihood of malignancy on a VAS. After a
full day training course with both groups (T1) and after
one year of continuous feedback (T2) with the interven-
tion group, we will repeat the picture scoring session
with both groups.
Intervention group
After the initial picture scoring sessions and the full day
training course, every GP will receive a Lumio loupe
(magnifying glass with integrated polarized light source
allowing subsurface examination) and a digital camera.
During his normal consultations, the GP takes pictures
with the digital camera of those skin lesions he wants to
get feedback on. The pictures are made anonymous and
sent by e-mail to an address, specially created for this
study. Alternatively, the memory cards with the pictures
will be sent once per week to the study centre.
Based on those pictures, a continuous problem based
feedback and teaching to the GPs will be conducted. As
kind of reminder, every GP will receive a monthly
update on the study, including the number of pictures
he sent to the Dermatologist compared to the number
of pictures sent by the other GPs in the intervention
group.
We will not change the current health care practice
for the patients; malignant suspicious lesions will be
removed immediately. In case of an additional teleder-
matological diagnosis “malignant suspicious”, the GP
will be informed directly and has to contact the patient
immediately to prevent a delay in excision and further
treatment.
Control group
GPs in the control group also join the initial picture
scoring sessions and the full day training course, but
they will receive neither the technical equipment nor
the continuous feedback until the end of the study.
After the end of our measurements, GPs in the control
group will also receive the Lumio loupe, the camera and
the possibility to send pictures of skin lesions for tele-
dermatological assessment.
Sample Size
The power calculation was based on data from previous
studies, as e.g. Gerbert et al. [6] who showed that the
improvement in correct answers with an educational
intervention could be about 13-36%. Due to the contin-
uous feedback via teledermatology we assume this effect
even to be greater.
Based on these assumptions, a power of 80% and a
significance level of 5% (alpha error) the sample size has
to be 53 GPs. With a drop out rate of 10% we con-
cluded that 60 GPs would be necessary.
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Randomisation and Blinding
Randomisation (intervention group or control group)
will take place at the GP level and will be carried out
centrally by the study centre. After the initial picture
scoring sessions and the full day training course, we will
draw up a randomisation list by computer (ralloc
command of Stata software for Windows, Version 11).
Blinding of the GPs is not possible.
Training course
The GPs in both groups will receive a full day training
course on skin cancer diagnosis which is going to be
Eligible GPs (n= .. GPs)
T0: Picture scoring session 1
„pre training test“
(n= .. GPs)
Allocated to the intervention group
(n= .. GPs)
Allocated to the control group
(n= .. GPs)
Not interested to join the study (n= .. GPs)
Not included because of financial limitations (n= .. GPs)
GPs provide usual careTechnical equipmentand continuous
educational feedback
Dermatologic training course
(n= .. GPs)
T2: Picture scoring session 3
(n= .. GPs)
Randomisation
(n= .. GPs)
T1: Picture scoring session 2
„post training test“
(n= .. GPs)
Drop out
(n= .. GPs)
Drop out
(n= .. GPs)
Figure 1 Study design.
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organized by Prof. Braun and his collaborators from the
Department of Dermatology of the University Hospital
Zurich. This training course will contain structured lec-
tures and interactive problem based teaching.
Time frame
The time frame of our study is shown in Figure 2. The
study is intended to last around 16 months from which
the intervention with the continuous feedback will last
12 months.
Data collection
For this study we will develop a pool of 108 example
cases (pictures of skin lesions we know the diagnosis,
supplemented with short histories), 36 cases at a high
difficulty level, 36 cases at a medium difficulty level and
36 cases at a low difficulty level. The levels of difficulty
will be defined by two Dermatologists independently.
For each of the three picture scoring sessions (at T0, T1
and T2), we will randomly allocate 36 cases (12 at each
level of difficulty). This random distribution will be
made prior to the start of the study to assure an equal
difficulty of each picture scoring session.
With the scoring session prior and after the interven-
tion, we measure the competence in skin cancer diagno-
sis of all participating GPs. We will record the
percentage of correct diagnoses made on the basis of
pictures with a short history. The GPs will have to score
the likelihood of malignancy on a VAS ("very unlikely”
to “very likely”).
From photographed patients in the GPs’ practices of
the intervention group, we will record some demo-
graphic and clinical information (age, sex, skin type,
parts of the body that were examined and the histology
of skin lesions that were excised). All patient data are
made anonymous and the encoding list is kept by the
GP.
Analysis
Prior to the start of the study, the pictures will be cate-
gorised by two Dermatologists independently into three
different levels of difficulty (low, medium or high level
of difficulty). For every level of difficulty, a cut-off on
the VAS will be defined previously to determine the cor-
rectness of the answers. This allows analysing the
answers corrected for the difficulty of the pictures.
The Chi-square test will be used for the primary out-
come. The presentation of the data will follow the
CONSORT-recommendations for reporting results of
randomised controlled trials [7].
Ethical principles
The study is being conducted in accordance with medi-
cal professional codex and the Helsinki Declaration as
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Time frame.
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of 1996 as well as Data Security Laws and Good Clinical
Practice criteria (GCP). Study participation of GPs and
patients is voluntary and can be cancelled at any time
without provision of reasons. The study protocol will be
registered at a trial register (current-controlled-trials)
and the study protocol will be published in an open
access journal, to be accessible for everybody.
GP and patient informed consent
Previous to study participation GPs receive written and
spoken information about the content and extent of the
planned study. In case of acceptance they sign the
informed consent form. Written informed consent will
also be obtained from patients prior to take pictures of
one of their skin lesions. In case of study discontinua-
tion all material will be destroyed or the GPs and
patients will be asked if they approve existing material
for analysis in the study.
Vote of the ethics committee (KEK-ZH-Nr. 2010-0384/5)
The study protocol has been approved by the ethics
committee of Zurich. A written and unrestricted positive
vote of the ethics committee was recorded on the 1st of
March 2011.
Data security and disclosure of original documents
The GP and patient names, pictures of skin lesions and
all other confidential information fall under medical
confidentiality rules and are treated according to appro-
priate Federal Data Security Laws. All study related data
and documents are stored on a protected central server
of the University of Zurich. Only direct members of the
internal study team can access the respective files. Inter-
mediate and final reports are stored at the Institute of
General Practice and at the Department of Dermatology
at the Zurich University Hospital (USZ).
Discussion
As shown in Figure 3 we expect an improvement of the
competence in skin cancer diagnosis after the full day
training course at T1 compared to T0 in both groups.
This improvement will probably fade away in the control
group after one year. It is known from different studies
[8,9] that the effect of a continuing medical education
(CME) is superior to the effect of single interventions.
Therefore, we expect at T2 a significant difference in the
competence in the diagnosis of skin cancer between the
Figure 3 Expected results.
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intervention group and the control group. We even
expect that in the intervention group, GPs will score bet-
ter at T2 than they did at T1, this would show the effect
of the continuous problem based teaching.
Limitations of the study
With our study, we do not investigate the influence of
our intervention on the mortality caused by skin can-
cers. Additionally, blinding of GPs is not possible.
List of abbreviations
BCC: basal cell carcinoma; GP: general practitioner; NMSC: nonmelanoma
skin cancer; SCC: squamous cell carcinoma; VAS: visual analogue scale
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